Arg-Gly-Asp (RGD)-based cyclopentapeptides (cRGDs) have a high affinity towards integrin αvβ3 and αvβ5, which are overexpressed by many tumor cells. Here, curcumin-loaded silk fibroin nanoparticles (SFNs) have been functionalized on the surface with cRGD to provide active targeting towards tumor cells; a “click reaction” between the RGD-based cyclopentapeptide carrying an azide group and triple-bond-functionalized nanoparticles has been exploited. Both naked and functionalized SFNs were less than 200 nm in diameter and showed a round-shaped morphology but, after functionalization, SFNs increased in size and protein molecular weight. The functionalization of SFNs’ surfaces with cRGD provided active internalization by cells overexpressing integrin receptors. At the lowest concentration tested (0.01 mg/mL), functionalized SFNs showed more effective uptake with respect to the naked by tumor cells that overexpress integrin receptors (but not for non-overexpressing ones). In contrast, at higher concentrations, the non-specific cell membrane protein–particle interactions are promoted and coupled to specific and target mediated uptake. Visual observations by fluorescence microscopy suggested that SFNs bind to integrin receptors on the cell surface and are then internalized by endocytosis. Overall, SFN functionalization provided in vitro active targeting for site-specific delivery of anticancer drugs, boosting activity and sparing healthy organs.

Silk fibroin nanoparticle functionalization with arg-gly-asp cyclopentapeptide promotes active targeting for tumor site-specific delivery / Bari E.; Serra M.; Paolillo M.; Bernardi E.; Tengattini S.; Piccinini F.; Lanni C.; Sorlini M.; Bisbano G.; Calleri E.; Torre M.L.; Perteghella S.. - In: CANCERS. - ISSN 2072-6694. - ELETTRONICO. - 13:5(2021), pp. 1185.1-1185.16. [10.3390/cancers13051185]

Silk fibroin nanoparticle functionalization with arg-gly-asp cyclopentapeptide promotes active targeting for tumor site-specific delivery

Piccinini F.;
2021

Abstract

Arg-Gly-Asp (RGD)-based cyclopentapeptides (cRGDs) have a high affinity towards integrin αvβ3 and αvβ5, which are overexpressed by many tumor cells. Here, curcumin-loaded silk fibroin nanoparticles (SFNs) have been functionalized on the surface with cRGD to provide active targeting towards tumor cells; a “click reaction” between the RGD-based cyclopentapeptide carrying an azide group and triple-bond-functionalized nanoparticles has been exploited. Both naked and functionalized SFNs were less than 200 nm in diameter and showed a round-shaped morphology but, after functionalization, SFNs increased in size and protein molecular weight. The functionalization of SFNs’ surfaces with cRGD provided active internalization by cells overexpressing integrin receptors. At the lowest concentration tested (0.01 mg/mL), functionalized SFNs showed more effective uptake with respect to the naked by tumor cells that overexpress integrin receptors (but not for non-overexpressing ones). In contrast, at higher concentrations, the non-specific cell membrane protein–particle interactions are promoted and coupled to specific and target mediated uptake. Visual observations by fluorescence microscopy suggested that SFNs bind to integrin receptors on the cell surface and are then internalized by endocytosis. Overall, SFN functionalization provided in vitro active targeting for site-specific delivery of anticancer drugs, boosting activity and sparing healthy organs.
2021
Silk fibroin nanoparticle functionalization with arg-gly-asp cyclopentapeptide promotes active targeting for tumor site-specific delivery / Bari E.; Serra M.; Paolillo M.; Bernardi E.; Tengattini S.; Piccinini F.; Lanni C.; Sorlini M.; Bisbano G.; Calleri E.; Torre M.L.; Perteghella S.. - In: CANCERS. - ISSN 2072-6694. - ELETTRONICO. - 13:5(2021), pp. 1185.1-1185.16. [10.3390/cancers13051185]
Bari E.; Serra M.; Paolillo M.; Bernardi E.; Tengattini S.; Piccinini F.; Lanni C.; Sorlini M.; Bisbano G.; Calleri E.; Torre M.L.; Perteghella S.
File in questo prodotto:
File Dimensione Formato  
0060_2021_Cancers_Bari_Compressed.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Altra tipologia di licenza compatibile con Open Access
Dimensione 1.13 MB
Formato Adobe PDF
1.13 MB Adobe PDF Visualizza/Apri
cancers-13-01185-s001.zip

accesso aperto

Tipo: File Supplementare
Licenza: Licenza per accesso libero gratuito
Dimensione 97.26 kB
Formato Zip File
97.26 kB Zip File Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/849972
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 14
social impact